Dental Barrier Membranes Market Size, Share & COVID19 Impact Analysis | Brazil | 2021-2027 | MedCore | Segmented by: Product (Emdogain®, GEM 21S®, Infuse™, Osteocel®)
- Year: 2017
- Scope: 2013-2023
- Region: Brazil
- Pages: 221
- Published Date: 3/1/2017
- Type: MedCore
Despite the dominance of resorbable products, the non-resorbable market continues to exhibit growth. Non-resorbable qualities are attractive in specific cases, with most of their appeal stemming from its relatively inexpensive price point. The bulk of non-resorbable membranes are titanium-based, which is available at a much less expensive price than alternative materials. The combination of the weak economy in Brazil and lack of government insurance makes the region a cost-sensitive environment.
Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.
Segments Covered in This Market
- Resorbable Dental Barrier Membrane Market
- Non-Resorbable Dental Barrier Membrane Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Geistlich is the market leader in both the dental bone graft substitute and dental membrane markets in Brazil. Geistlich has a highly visible presence in the dental regenerative products market owing to the popularity of its Bio-Oss® xenograft product. Critéria is comprised of medical experts based out of São Paulo, Brazil. It is equipped with its own professional research staff that perform clinical tests on its product, thereby providing innovative solutions. Zimmer Biomets sales force put greater emphasis on selling its regenerative product line, which helped increase its market presence. Other companies analyzed include Nobel Biocare, Sistema INP and Baumer.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled Brazil Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials – MedSuite
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Dental Barrier Membranes Market Size, Share & COVID19 Impact Analysis | Brazil | 2021-2027 | MedCore | Segmented by: Product (Emdogain®, GEM 21S®, Infuse™, Osteocel®)
$295 – $5,995
Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.
- 2017
- 2013-2023
- Brazil
- 3/1/2017
- 221
- MedCore
Related Reports
